LPA and acute liver failure: We recently showed that in both the ACLF and acute liver failure (ALF) settings, this axis was associated with outcomes and that the modulation of LPA, acting through their specific receptor (lysophosphatidic acid receptor [LPAR]), has the potential to reverse the pro-restorative phenotype of circulating monocytes.15